A detailed history of City Holding CO transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, City Holding CO holds 37 shares of BIO stock, worth $12,635. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37
Previous 37 -0.0%
Holding current value
$12,635
Previous $10,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

SELL
$268.26 - $339.48 $4,023 - $5,092
-15 Reduced 28.85%
37 $10,000
Q1 2024

Apr 11, 2024

SELL
$304.11 - $351.99 $3,041 - $3,519
-10 Reduced 16.13%
52 $17,000
Q4 2023

Jan 10, 2024

SELL
$269.37 - $365.04 $64,379 - $87,244
-239 Reduced 79.4%
62 $20,000
Q3 2023

Oct 13, 2023

SELL
$350.25 - $422.63 $176,526 - $213,005
-504 Reduced 62.61%
301 $107,000
Q2 2023

Jul 13, 2023

SELL
$359.49 - $486.4 $208,504 - $282,112
-580 Reduced 41.88%
805 $305,000
Q1 2023

Apr 17, 2023

BUY
$418.69 - $503.0 $48,149 - $57,845
115 Added 9.06%
1,385 $663,000
Q4 2022

Jan 27, 2023

SELL
$351.71 - $456.01 $5,275 - $6,840
-15 Reduced 1.17%
1,270 $0
Q3 2022

Oct 12, 2022

BUY
$412.59 - $563.26 $10,314 - $14,081
25 Added 1.98%
1,285 $536,000
Q2 2022

Jul 08, 2022

BUY
$463.67 - $597.16 $23,183 - $29,858
50 Added 4.13%
1,260 $624,000
Q1 2022

Apr 15, 2022

BUY
$524.57 - $735.42 $70,816 - $99,281
135 Added 12.56%
1,210 $681,000
Q4 2021

Mar 11, 2022

BUY
$708.84 - $794.68 $209,107 - $234,430
295 Added 37.82%
1,075 $673,000
Q3 2021

Oct 15, 2021

BUY
$657.71 - $825.77 $338,720 - $425,271
515 Added 194.34%
780 $582,000
Q2 2021

Jul 15, 2021

BUY
$576.64 - $649.04 $152,809 - $171,995
265 New
265 $171,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.41B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track City Holding CO Portfolio

Follow City Holding CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of City Holding CO, based on Form 13F filings with the SEC.

News

Stay updated on City Holding CO with notifications on news.